Participating in a clinical trial allows those who have been diagnosed with a serious illness, like mesothelioma, to contribute to medical research. Each clinical trial has unique criteria and guidelines that prospective participants must meet in order to be considered for inclusion in the study. Because there are both benefits and risks to participating in a clinical trial it is always best to discuss any interest you may have with your doctor. Provided below is a list of active mesothelioma clinical trials that are still recruiting and enrolling participants. Click on a link to learn more about each study and the criteria for participation.
BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: July 13, 2020
Status: Recruiting
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: July 13, 2020
Status: Recruiting
Olaparib in People With Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: July 11, 2020
Status: Recruiting
Dose Individualization of Pemetrexed - IMPROVE-I
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Last Updated: July 10, 2020
Status: Recruiting
Dose Individualization of Pemetrexed - IMPROVE-III
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Last Updated: July 10, 2020
Status: Recruiting
First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin
Conditions: Adenocarcinoma, Mesothelioma
Last Updated: July 9, 2020
Status: Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Carcinoma, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Breast Neoplasms, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Cystadenocarcinoma, Serous, Carcinoma, Endometrioid, Paraganglioma, Chordoma, Fibromatosis, Aggressive, Hemangiosarcoma, Trophoblastic Neoplasms, Adenocarcinoma, Mucinous, Gestational Trophoblastic Disease, Adenocarcinoma, Clear Cell, Nerve Sheath Neoplasms, Neurofibrosarcoma, Fibroma, Thyroid Neoplasms, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Mixed Tumor, Mullerian, Neoplasms, Unknown Primary, Carcinoma, Giant Cell, Neoplasms
Last Updated: July 9, 2020
Status: Recruiting
A Study of SGN-CD228A in Advanced Solid Tumors
Conditions: Adenocarcinoma, Mesothelioma
Last Updated: July 6, 2020
Status: Recruiting
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Conditions: Neoplasm Metastasis, Astrocytoma, Brain Neoplasms, Mesothelioma, Cholangiocarcinoma, Tongue Neoplasms, Esophageal Neoplasms, Thymoma, Urologic Neoplasms
Last Updated: July 2, 2020
Status: Recruiting
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Conditions: Esophageal Neoplasms, Mesothelioma, Neoplasms
Last Updated: June 30, 2020
Status: Recruiting
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: June 29, 2020
Status: Recruiting
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Conditions: Carcinoma, Renal Cell, Mesothelioma
Last Updated: June 26, 2020
Status: Recruiting
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors
Conditions: Adenocarcinoma, Mesothelioma, Cholangiocarcinoma
Last Updated: June 26, 2020
Status: Recruiting
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
Conditions: Carcinoma, Merkel Cell, Carcinoma, Carcinoma, Squamous Cell, Mesothelioma, Neuroendocrine Tumors, Nasopharyngeal Carcinoma, Lung Neoplasms, Carcinoma, Neuroendocrine
Last Updated: June 18, 2020
Status: Recruiting
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: June 18, 2020
Status: Recruiting
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Conditions: Uterine Cervical Neoplasms, Mesothelioma, Carcinoma, Non-Small-Cell Lung, Thymoma, Thymus Neoplasms
Last Updated: June 15, 2020
Status: Recruiting
Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: June 12, 2020
Status: Recruiting
HMPL-453 in Advanced Malignant Mesothelioma
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: June 12, 2020
Status: Recruiting
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Conditions: Mesothelioma, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma, Biliary Tract Neoplasms, Neoplasms
Last Updated: June 12, 2020
Status: Recruiting
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma
Conditions: Mesothelioma
Last Updated: June 11, 2020
Status: Recruiting
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
Conditions: Melanoma, Carcinoma, Renal Cell, Mesothelioma, Cholangiocarcinoma, Neoplasms
Last Updated: June 5, 2020
Status: Recruiting
Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors
Conditions: Carcinoma, Sarcoma, Glioblastoma, Mesothelioma, Neuroendocrine Tumors, Endometrial Neoplasms, Stomach Neoplasms, Neoplasms
Last Updated: June 5, 2020
Status: Recruiting
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Neoplasms
Last Updated: June 4, 2020
Status: Recruiting
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: June 3, 2020
Status: Recruiting
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Conditions: Neoplasms
Last Updated: June 2, 2020
Status: Recruiting
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
Conditions: Mesothelioma
Last Updated: June 1, 2020
Status: Recruiting
CAR T Cells in Mesothelin Expressing Cancers
Conditions: Adenocarcinoma, Mesothelioma, Fallopian Tube Neoplasms, Adenocarcinoma of Lung
Last Updated: May 29, 2020
Status: Recruiting
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for the Treatment of Resectable, Refractory, or Recurrent Abdominal or Pelvic Tumors in Pediatric Patients, T.O.A.S.T. I.T. Study
Conditions: Carcinoma, Sarcoma, Mesothelioma, Rhabdomyosarcoma, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Lung Neoplasms, Liposarcoma, Fallopian Tube Neoplasms, Stomach Neoplasms, Rectal Neoplasms, Desmoplastic Small Round Cell Tumor, Colonic Neoplasms, Abdominal Neoplasms, Pelvic Neoplasms, Neoplasms
Last Updated: May 28, 2020
Status: Recruiting
Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53
Conditions: Neoplasms
Last Updated: May 27, 2020
Status: Recruiting
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
Conditions: Mesothelioma
Last Updated: May 25, 2020
Status: Recruiting
Phase 1/2 Trial of TC-210 T Cells in Patients With Advanced Mesothelin-Expressing Cancer
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Cholangiocarcinoma
Last Updated: May 21, 2020
Status: Recruiting
Oral TrkA Inhibitor VMD-928 for Treatment of Advanced Adult Solid Tumors or Lymphoma
Conditions: Lymphoma, Carcinoma, Prostatic Neoplasms, Melanoma, Carcinoma, Squamous Cell, Leukemia, Myeloid, Acute, Ovarian Neoplasms, Lymphoma, Non-Hodgkin, Carcinoma, Hepatocellular, Stomach Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Mesothelioma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Adenoid Cystic, Pancreatic Neoplasms, Thymoma, Lung Neoplasms
Last Updated: May 18, 2020
Status: Recruiting
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Conditions:
Last Updated: May 14, 2020
Status: Recruiting
Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid Tumors
Conditions: Melanoma, Mesothelioma, Lung Neoplasms, Skin Neoplasms, Bone Neoplasms, Genital Neoplasms, Female, Soft Tissue Neoplasms, Endocrine Gland Neoplasms, Pharyngeal Neoplasms, Mouth Neoplasms, Thyroid Neoplasms, Genital Neoplasms, Male, Urologic Neoplasms, Sarcoma, Thyroid Diseases, Recurrence, Neoplasms
Last Updated: May 13, 2020
Status: Recruiting
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Mesothelioma, Nasopharyngeal Carcinoma, Breast Neoplasms, Cholangiocarcinoma, Lung Neoplasms, Carcinoma, Basal Cell, Squamous Cell Carcinoma of Head and Neck, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Thymoma, Small Cell Lung Carcinoma, Anus Neoplasms, Vulvar Neoplasms
Last Updated: May 12, 2020
Status: Recruiting
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Conditions: Mesothelioma, Pleural Diseases
Last Updated: May 11, 2020
Status: Recruiting
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
Conditions: Carcinoma, Merkel Cell, Lymphoma, Carcinoma, Endometrial Neoplasms, Mesothelioma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell
Last Updated: May 11, 2020
Status: Recruiting
Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Conditions: Stomach Neoplasms, Esophageal Neoplasms, Mesothelioma, Gastrointestinal Stromal Tumors, Anus Neoplasms, Pancreatic Neoplasms, Liver Neoplasms, Carcinoma, Hepatocellular, Gastrointestinal Neoplasms
Last Updated: May 7, 2020
Status: Recruiting
177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours
Conditions: Mesothelioma, Neuroendocrine Tumors, Thymoma
Last Updated: May 3, 2020
Status: Recruiting
A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: April 27, 2020
Status: Recruiting
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: April 27, 2020
Status: Recruiting
Rapid Autopsy and Procurement of Cancer Tissue
Conditions: Mesothelioma, Urogenital Neoplasms
Last Updated: April 24, 2020
Status: Recruiting
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: April 20, 2020
Status: Recruiting
Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients With PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies
Conditions: Mesothelioma, Disease Progression
Last Updated: April 20, 2020
Status: Recruiting
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
Conditions: Sarcoma, Mesothelioma, Lung Neoplasms, Esophageal Neoplasms, Neoplasms, Germ Cell and Embryonal, Thymus Neoplasms, Neoplasms
Last Updated: April 17, 2020
Status: Recruiting
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
Conditions: Mesothelioma
Last Updated: April 17, 2020
Status: Recruiting
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
Conditions: Neoplasm Metastasis
Last Updated: April 1, 2020
Status: Recruiting
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
Conditions: Mesothelioma
Last Updated: March 25, 2020
Status: Recruiting
First-in-human Study of S-588210 (S-488210+S-488211)
Conditions: Mesothelioma
Last Updated: March 19, 2020
Status: Recruiting
A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors
Conditions: Neoplasms
Last Updated: March 18, 2020
Status: Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Conditions: Adenocarcinoma, Sarcoma, Mesothelioma
Last Updated: March 11, 2020
Status: Recruiting
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Conditions: Carcinoma, Merkel Cell, Mesothelioma, Neuroendocrine Tumors, Neoplasms, Squamous Cell, Carcinoma, Squamous Cell, Microsatellite Instability
Last Updated: March 10, 2020
Status: Recruiting
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Conditions: Mesothelioma
Last Updated: March 5, 2020
Status: Recruiting
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
Conditions: Mesothelioma
Last Updated: March 4, 2020
Status: Recruiting
Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for Malignant Pleural Mesotheliomas
Conditions: Mesothelioma
Last Updated: March 3, 2020
Status: Recruiting
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Conditions: Neoplasms
Last Updated: February 19, 2020
Status: Recruiting
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Stomach Neoplasms, Small Cell Lung Carcinoma, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Neoplasms
Last Updated: February 14, 2020
Status: Recruiting
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
Conditions: Mesothelioma, Wilms Tumor
Last Updated: February 10, 2020
Status: Recruiting
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: January 29, 2020
Status: Recruiting
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Carcinoma, Transitional Cell
Last Updated: January 24, 2020
Status: Recruiting
Study of SO-C101 and SO-C101in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors
Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Squamous Cell, Ovarian Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Uterine Cervical Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Small Cell Lung Carcinoma, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Biliary Tract Neoplasms, Anus Neoplasms, Thymus Neoplasms, Microsatellite Instability
Last Updated: January 15, 2020
Status: Recruiting
Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed
Conditions: Mesothelioma
Last Updated: December 13, 2019
Status: Recruiting
TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients
Conditions: Mesothelioma
Last Updated: December 13, 2019
Status: Recruiting
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Conditions: Leukemia, Multiple Myeloma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Mesothelioma, Sarcoma, Synovial, Esophageal Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms
Last Updated: December 10, 2019
Status: Recruiting
Autologous Dendritic Cell Vaccination in Mesothelioma
Conditions: Mesothelioma
Last Updated: December 6, 2019
Status: Recruiting
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C
Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Appendiceal Neoplasms, Fever
Last Updated: December 4, 2019
Status: Recruiting
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
Conditions: Mesothelioma, Lung Neoplasms
Last Updated: December 2, 2019
Status: Recruiting
Short Neoadjuvant Hemithoracic IMRT for MPM
Conditions: Mesothelioma
Last Updated: November 25, 2019
Status: Recruiting
Dose Individualization of Pemetrexed - IMPROVE-II
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma
Last Updated: November 20, 2019
Status: Recruiting
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection
Conditions: Mesothelioma
Last Updated: November 18, 2019
Status: Recruiting
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
Conditions: Mesothelioma
Last Updated: November 13, 2019
Status: Recruiting
Mesothelioma and Radical Surgery 2
Conditions: Mesothelioma
Last Updated: October 28, 2019
Status: Recruiting
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Small Cell Lung Carcinoma, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Microsatellite Instability
Last Updated: October 22, 2019
Status: Recruiting
Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma
Conditions: Adenocarcinoma, Mesothelioma, Carcinoma, Ovarian Epithelial
Last Updated: October 21, 2019
Status: Recruiting
Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma
Conditions: Lung Neoplasms, Mesothelioma
Last Updated: October 17, 2019
Status: Recruiting
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: October 15, 2019
Status: Recruiting
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors
Conditions: Endometrial Neoplasms, Mesothelioma, Carcinoma, Ovarian Epithelial, Kidney Neoplasms, Carcinoma, Hepatocellular
Last Updated: October 10, 2019
Status: Recruiting
Integrated Cancer Repository for Cancer Research
Conditions: Multiple Myeloma, Pancreatic Neoplasms, Esophageal Neoplasms, Endometrial Neoplasms, Thyroid Neoplasms, Mesothelioma, Neuroendocrine Tumors, Salivary Gland Neoplasms, Anus Neoplasms, Gallbladder Neoplasms, Bile Duct Neoplasms, Oropharyngeal Neoplasms, Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Vaginal Neoplasms, Urethral Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Adenomatous Polyposis Coli, Testicular Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Intestinal Neoplasms, Hypopharyngeal Neoplasms, Penile Neoplasms, Ureteral Neoplasms, Peritoneal Neoplasms, Neoplasms, Plasma Cell, Paranasal Sinus Neoplasms, Duodenal Neoplasms, Neoplasms, Unknown Primary, Lip Neoplasms, Thymus Neoplasms, Paraproteinemias, Neoplasms
Last Updated: October 8, 2019
Status: Recruiting
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
Conditions: Mesothelioma, Gallbladder Neoplasms, Pancreatic Neoplasms, Pseudomyxoma Peritonei, Appendiceal Neoplasms, Pleural Effusion, Ascites
Last Updated: October 7, 2019
Status: Recruiting
MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: October 4, 2019
Status: Recruiting
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Neoplasms, Fibrous Tissue, Solitary Fibrous Tumors, Solitary Fibrous Tumor, Pleural, Pleural Neoplasms
Last Updated: October 2, 2019
Status: Recruiting
Staging Procedures to Diagnose Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Neoplasms, Fibrous Tissue, Solitary Fibrous Tumors, Solitary Fibrous Tumor, Pleural, Pleural Neoplasms
Last Updated: October 2, 2019
Status: Recruiting
Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
Conditions: Mesothelioma, Neoplasms, Fibrous Tissue, Solitary Fibrous Tumors, Solitary Fibrous Tumor, Pleural, Pleural Neoplasms
Last Updated: October 2, 2019
Status: Recruiting
Intrapleural Cryotherapy for Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: October 1, 2019
Status: Recruiting
Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma
Conditions: Mesothelioma
Last Updated: September 25, 2019
Status: Recruiting
Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma
Conditions: Mesothelioma
Last Updated: September 18, 2019
Status: Recruiting
Phase I Trial HIPEC With Nal-irinotecan
Conditions: Adenocarcinoma, Mesothelioma, Adenocarcinoma, Mucinous, Cystadenocarcinoma, Pseudomyxoma Peritonei
Last Updated: September 17, 2019
Status: Recruiting
Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
Conditions: Mesothelioma
Last Updated: August 15, 2019
Status: Recruiting
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: August 6, 2019
Status: Recruiting
APG-2449 in Patients With Advanced Solid Tumors
Conditions: Mesothelioma
Last Updated: June 20, 2019
Status: Recruiting
Phase I Trial of Adjuvant Pembrolizumab After Radiation Therapy for Lung-Intact Malignant Pleural Mesothelioma
Conditions: Mesothelioma
Last Updated: May 15, 2019
Status: Recruiting
Rehabilitation by Effort for Patients With Advanced Bronchial Cancer
Conditions: Mesothelioma, Carcinoma, Bronchogenic
Last Updated: April 16, 2019
Status: Recruiting
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Conditions: Mesothelioma, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Uterine Neoplasms, Fever
Last Updated: April 15, 2019
Status: Recruiting
Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma
Conditions: Mesothelioma, Fever
Last Updated: April 15, 2019
Status: Recruiting
MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma.
Conditions: Mesothelioma, Pleural Effusion
Last Updated: January 25, 2019
Status: Recruiting
Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study
Conditions: Lymphoma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Mesothelioma, Sarcoma, Synovial, Rhabdoid Tumor, Kidney Neoplasms
Last Updated: January 8, 2019
Status: Recruiting
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Conditions: Mesothelioma, Carcinoma, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Fever
Last Updated: October 15, 2018
Status: Recruiting
DENdritic Cell Immunotherapy for Mesothelioma
Conditions: Mesothelioma
Last Updated: July 31, 2018
Status: Recruiting
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)
Conditions: Mesothelioma, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms
Last Updated: March 16, 2018
Status: Recruiting
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Conditions: Carcinoma, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Carcinoma, Neuroendocrine
Last Updated: November 18, 2016
Status: Recruiting
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Conditions: Carcinoma, Mesothelioma, Colorectal Neoplasms, Pseudomyxoma Peritonei, Peritoneal Neoplasms, Neoplasms
Last Updated: October 14, 2015
Status: Recruiting
